ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Preclinical activity of the rational combination of selumetinib (AZD6244) in combination with vorinostat in KRAS-mutant colorectal cancer models.

M Pia Morelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.